what is tirzepatide and semaglutide vs for Weight Loss Semaglutide/Tirzepatide: Beyond Weight Loss: Shamsah

STEP 1 Trial (2021) The landmark trial enrolled 1,961 adults with obesity or overweight (without diabetes) and randomised them to semaglutide 2.4 mg weekly or placebo for 68 weeks, alongside lifestyle intervention

These changes have created an environment conducive to the swift uptake of new treatments

Hypertension impairs glymphatic clearance of A through reduction of arterial pulsation Given that glymphatic clearance of interstitial solutes is highly dependent on vascular pulsatility, we hypothesized that hypertension influences pulsatility, in turn, impairing lymphatic clearance

Untreated and persistent dehydration may lead to kidney damage

M.OliveriaJ